Cytek Biosciences, Inc.
Cytek Biosciences, Inc.（CTKB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CTKB · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Cytek Biosciences, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CTKB 季度内部人买卖趋势
CTKB 内幕交易卖出 · CTKB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CTKB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CTKB 高管卖出股份 · CTKB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2026 | Holder Michael Director | Option | 1,454 | — | Form 4 |
| May 18, 2026 | Chin Richard Director | Option | 6,107 | — | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Option | 9,480 | — | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Other | 2,364 | $8K | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Option | 4,108 | — | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Other | 1,025 | $4K | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Option | 3,683 | — | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Other | 919 | $3K | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Option | 4,908 | — | Form 4 |
| May 18, 2026 | Yan Ming CHIEF TECHNOLOGY OFFICER · Director | Other | 1,224 | $4K | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Option | 5,551 | — | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Other | 1,424 | $5K | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Option | 2,416 | — | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Other | 620 | $2K | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Option | 1,473 | — | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Other | 378 | $1K | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Option | 1,024 | — | Form 4 |
| May 18, 2026 | Busque Philippe SVP, GLOBAL SALES AND SERVICES | Other | 263 | $934 | Form 4 |
| May 18, 2026 | Jiang Wenbin PRESIDENT AND CEO · Director | Option | 38,141 | — | Form 4 |
| May 18, 2026 | Jiang Wenbin PRESIDENT AND CEO · Director | Other | 15,009 | $53K | Form 4 |
| May 18, 2026 | Jiang Wenbin PRESIDENT AND CEO · Director | Option | 19,334 | — | Form 4 |
| May 18, 2026 | Jiang Wenbin PRESIDENT AND CEO · Director | Other | 5,032 | $18K | Form 4 |
| May 18, 2026 | Jiang Wenbin PRESIDENT AND CEO · Director | Option | 14,733 | — | Form 4 |
| May 18, 2026 | Jiang Wenbin PRESIDENT AND CEO · Director | Other | 3,588 | $13K | Form 4 |
| May 18, 2026 | Jiang Wenbin PRESIDENT AND CEO · Director | Option | 7,854 | — | Form 4 |
Busque Philippe
SVP, GLOBAL SALES AND SERVICES
日期
May 18
股数
1,424
均价
$3.55
总金额
$5K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CTKB 内幕交易
CTKB 内幕交易
Cytek Biosciences, Inc.（CTKB）内幕交易数据来源于公司内部人（包括Busque Philippe (SVP, GLOBAL SALES AND SERVICES), Jiang Wenbin (PRESIDENT AND CEO · Director), Barnett Valerie (CHIEF LEGAL OFFICER)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CTKB内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cytek Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CTKB 内幕交易 · 5个问题Cytek Biosciences, Inc.（CTKB）的内部人包括高管和董事，如Busque Philippe (SVP, GLOBAL SALES AND SERVICES), Jiang Wenbin (PRESIDENT AND CEO · Director), Barnett Valerie (CHIEF LEGAL OFFICER)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026